» Dean's Professional Advisory Group

photo of Nazli Azimi, Pharm.D., Ph.D.

Nazli Azimi, Pharm.D., Ph.D.

Founder & Chief Executive Officer, Bioniz Therapeutics
Irvine, CA
Dr. Azimi is Bioniz’ founder, co-inventor of its core technology, and has served as the Company’s Chief Executive Officer since its inception. After graduating from the University of Tehran with a doctorate in pharmacy in 1992, Dr. Azimi completed her post-doctoral immunology program at one of the premier research groups at the National Institutes of Health (NIH), directed by Dr. Thomas Waldmann, a pioneer in the field of immune-therapy. During a decade of research at the NIH as a post-doctoral fellow and an independent scientist, Dr. Azimi made seminal contributions to the field of immunology, which later became the foundation for Bioniz’s platform technology. In 2004, Dr. Azimi joined the faculty at the Fred Hutchinson Cancer Research Center, where she studied immune cytokine responses to herpes virus. Prior to founding Bioniz, Dr. Azimi served as founder and CEO of Dermaheal USA, a privately held dermatology company. Dr. Azimi has authored over 30 peer-reviewed, high impact scientific publications and is the inventor of more than a dozen patents, including the Bioniz intellectual property patent estate.
photo of Al  Babbington

Al Babbington

Founder and former CEO, Irvine Pharmaceutical Services
Irvine, CA
Al Babbington has spent more than 30 years funding and leading businesses which focus on developing disruptive technologies that create value. His mission, both personally and professionally, is to help improve health in America and around the world. Al Babbington is currently the CEO of PrescribeWellness, the pharmacy patient communication tool that is changing the role of the community pharmacy from a dispensary to a center for preventive healthcare and wellness. His companies have been listed 6 times on Inc. 5000 List of Fastest-Growing Private Companies. He also serves as a National Community Pharmacists Association (NCPA) Innovation board member and director of New Leaf Africa, an organization dedicated to applying carbon credits to sustainable projects that improve health and education. For his innovation, he is recognized in the 45 over 45: Entrepreneurs Over Age 45 Who are Disrupting the Way We Do Business.
photo of Phillip Brancazio, MBA

Phillip J. Brancazio, MBA

Senior Vice President and General Manager, Par Pharmaceutical - an Endo Company
Irvine, CA
Mr. Brancazio has over 40 years of pharmaceutical and medical device industry experience. His career includes 23 years in Quality and Operations management with Bristol-Myers Squibb, and 12 years in Operations Management with DPT Labs, Andrx Pharmaceuticals (now Teva) and Haemonetics prior to joining Par in 2011. His experience includes managing and directing international supply chain, engineering, pharmaceutical technology and manufacturing organizations for the companies where he worked.
Phil has a Bachelor of Science Degree in Microbiology with a minor in Chemistry from Texas A&M University in 1974 and earned a Masters in Business Administration from the University of North Carolina, Greensboro in 1987. He is a member of ISPE, AAPS, ASQ and the 12th Man Foundation Texas A&M University.
photo of Kal Chatto, M.S. Pharm.

Kal Chatto, M.S. Pharm.

Co-Founder Genom Global Venture (A Division of Genom LIfe Sciences)
Mr. Kal Chatto, is an entrepreneur and business executive with 30 plus years’ worth of expertise and experience in the biotech & pharmaceutical world. Mr. Chatto is an Adjunct Professor at Chapman University School of Pharmacy. He was also an Adjunct Visiting Professor for 4 years (3/'13-3/'17), Manipal College of Pharmaceutical Sciences, Manipal University ranked #1 in India.
In 2005, as the Co-Founder and Board Member, Mr.Chatto helped in building and shaping Manipal Acunova, which acquired Ecron, a top European Contract Research Organization (CRO) and became Ecron Acunova (EA), one of the most successful international CROs (Privately held). Ecron Acunova won the prestigious Proximire Award and Bio-Excellence Award and EA was acquired by Take Solutions in FY 2015- 2016. In 2007, he became the Co-Founder and Board member of Avitacor, LLC, a CRO focusing on Latin America, which was sold to a private investors group in Mexico.
In 1988, Mr. Chatto was recruited from the Glaxo Pharmaceutical's (now GSK) Marketing and Sales Leadership Team to be one the first 9 Amgen Founding Marketing and Sales leaders to launch and commercialize a major breakthrough biotech product, EPOGEN, followed by the world's top selling biotech medicines Neupogen, Aranesp, Neulasta and Enbrel. Mr. Chatto relentlessly contributed to Amgen's paramount success (market cap from $100 Million to $75.17 Billion in Q4'04) in becoming one the best biotech companies worldwide by improving values for patients, payers & providers, and stockholders.
Mr. Chatto was Co-Chair of the Host Committee for the 2004 FIP World Congress, New Orleans, U.S.A. In 2005, Mr. Chatto was awarded the "FIP Distinguished Service Award" by the International Pharmaceutical Federation (FIP) in recognition of his exceptional and distinguished contribution to FIP. Recognized globally, the award honors outstanding achievers who inspire others with their vision and leadership. Mr. Chatto also served on the board of leading professional organizations such as Federation of International Pharmacy (FIP) for Education and Research, American College of Clinical Pharmacy (ACCP) Research Institute as well as key pharmacy schools at the University of Arizona, University of Wisconsin, University of Tennessee, and USC.
Mr. Chatto received his B.Pharm from IIT (B.H.U) and M.S. in Pharmacy Administration from Long Island University, New York. He also completed Executive Management Programs from Marshall School of Business, USC, and Anderson School of Management at UCLA.
photo of Reginald Gilyard, M.B.A.

Reginald Gilyard, M.B.A.

Senior Advisor, The Boston Consulting Group
Reginald (Reggie) H. Gilyard is a Senior Advisor with The Boston Consulting Group (BCG) - a $5B+ global management consulting company which advises the world's largest companies and public institutions.
Reggie was formerly a Partner and Managing Director in the Los Angeles office of BCG, where he led BCG's Education practice in the US, focused on not-for-profit institutions. In addition, he served private sector clients in the retail, consumer goods, media and technology sectors. Outside of client work, Reggie led both local and specialized national recruiting programs for BCG; covering undergraduate, MBA, PhD and lateral hiring programs.
Reggie previously served as a member of the BCG America’s Leadership Team, one of three company-wide regional boards. In addition, he currently sits on the board of the First American Financial Corporation, the Pacific Charter School Development corporation, and also the board of OCTANE. Prior to BCG, Reggie served in the U.S. Air Force as a Program Manager responsible for the development, production and fielding of global intelligence systems procured through government contractors.
Reggie is a 1985 graduate of the U.S. Air Force Academy where he received a BS in Mathematics/Operations Research, a 1989 graduate of the Air Force Institute of Technology where he received an MS in Computer Systems, and a 1996 graduate of the Harvard Business School where he received an MBA.
photo of Linda A. Grace, RN, ADN, BSHS

Linda A. Grace, RN, ADN, BSHS

President COSTech/KBM Business Management, Owner CDM Drugs
Corona Del Mar, CA
Over 30 years experience in the field of professional business and health care management, Linda Grace has extensive knowledge and experience in directing and managing all functional areas of the healthcare system. After receiving her R.N., Associates Degree at the State University New York and acquiring multiple certifications including Intravenous Therapy Certification, CRNI, Chemotherapy Certification, PICC Certification, Medical Coding, Billing, she went on to receive her B.S., Health Science from Chapman University, Orange, CA.
Her hands on clinical career included CCU, Post Open Heart, Surgical GYN, Oncology and Home Infusion Pharmacy. Working for several public and private national Home Infusion Pharmacies including Avon’s Foster Medical and Infusion Care, WR Grace’s NMC Home Care and Curaflex/Coram; she held the position of Vice President of Operations and Clinical Pharmacy and Nursing Services as well as President and founder of Curaflex’s Mail Order Pharmacy. Publishing multiple articles and a textbook chapter on intravenous therapy, she taught both nurses and pharmacist’s the art of Intravenous Therapy.
Linda went on to become a partner in Sutherland and Associates/Partners Consulting Group, an international pharmacy and hospital consulting firm. She served as Executive Director for the National Association for Vascular Access Networks (NAVAN) and Editor in Chief for their professional journal before starting COSTech, a California based consulting organization. COSTech emerged as a muti-dimensional health care management group focusing on all aspects of healthcare including financial feasibility and business management, regulatory management, compliance, quality management and accreditation services. It adapted to the ever-changing health care environment evolving to include turn-around, re-engineering, new start-up, marketing and sales, growth and expansion as well as social media services for Physician practices as well as pharmacy. Linda has enjoyed mentoring physicians in business growth and management for the past 15 years.
She currently owns several businesses including a Health Care Consulting Management Company, a full service retail, compounding and home infusion pharmacy and two wineries. Linda continues to consult with Physicians on a project basis and acts as Quality, Regulatory and Compliance Officer for CDM Drugs and Community Infusion Services.
For fun, Linda is working on her second career as proprietor of Giracci Vineyards and Farms and Cowboy Canyon Winery, a group of family owed wineries in Orange County. Linda is an ardent supporter of philanthropic causes in Orange County, and is involved in several charities currently sitting on the Board of Directors for Laura’s House and the Silverado Modjeska Recreation and Parks Department while supporting other charities such as CHOC and the Roosters Foundation. She enjoys spending time with her husband and four children. With a lifelong passion for quality of patient care she is dedicated to assisting the community in adapting to the changes in the healthcare environment.
photo of Tom Hill, PharmD

Tom Hill, PharmD

Vice President of Operations, St. Joseph Hospital
Orange, CA
Tom Hill, Pharm.D, is a hospital executive with 39 years of hospital operations experience. He is currently Vice President of Operations at St. Joseph Hospital in Orange, California. In this role he oversees hospital operations in areas including all facility Support Services, Clinical Ancillary Departments (Pharmacy, PT/OT, and Speech), Outpatient Clinical Services (Center for Cancer Prevention and Treatment, Dialysis and Transplant Center, Wound Care Center) and facility Design and Construction.
Prior to joining the St. Joseph Health System, Tom spent 26 years at St. Mary Medical Center in Long Beach with progressive leadership responsibilities in the areas of Pharmacy, Quality Management, Utilization Management, Risk Management and Safety and Operations (all support and ancillary services). From 1978 – 1993 Tom also held the position of Assistant Clinical Professor of Pharmacy with the University of Southern California School of Pharmacy.
Dr. Hill received his Bachelor’s Degree in Biology (University of Oregon) in 1970 and his Bachelor’s Degree in Pharmacy (Creighton University) in 1973. He earned his Doctorate Degree in Pharmacy from the University of Southern California in 1974.
In addition to his role at the hospital, Tom is also active in the community and has held several community service positions serving as a Member of the Board of Directors for the Long Beach Metropolitan YMCA (1998-2000) and the YMCA of Orange (2001-2003). Since 2003 he has been active in a leadership role with the Orange Chamber of Commerce, serving as a Board of Directors Member since 2003 and the CFO from 2006-2009.
Tom lives a very active lifestyle. He enjoys all outdoor activities including camping, fishing and golf. He especially enjoys spending time with his family and friends. He is married and has two daughters.
photo of Brian Jones

Brian Jones

VP and General Manager, Siegfried
Irvine, CA
Brian Jones has over 35 years of experience in the field of pharmaceutical manufacturing operations directing and managing all functional levels of both small and large scale commercial production and development products for clinical trials. After receiving his B.S in Biological Sciences from U.C. Irvine, he performed medical technology support at U.C.I.M.C. laboratories functioning in a number of roles within the hospital environment. Thereafter, he performed large-scale commercial manufacturing operations with Procter & Gamble where he began his management career; which included engineering and facility support functions while gaining progressive leadership responsibilities for manufacturing consumer products.
Brian’s interest in providing products that improved human health compelled him to further his education with graduate studies in Human Biology at C.S.U.D.H., and applying his knowledge and management skills to produce healthcare products such as sterile and solid oral dosage drugs. His career has spanned development of new formulations and sterile filling of parenteral products which occurred at McGaw, International Medication Systems, Watson Laboratories, Teva Parenterals, and CIMA Labs with new fast-dissolve technologies and use of robotics. He has expanded his career in pharmaceutical operations for contract manufacturing of drug products for the past seven years with Siegfried Pharmaceuticals in Irvine, CA, where the latest technologies for sterile drug delivery of small and large molecule products are scaled to commercial delivery.
Brian is licensed with the State of California as a Designated Representative License Drug Wholesaler and has been a Board member of the International Society of Pharmaceutical Engineers (ISPE). As a longtime resident of Irvine since his attendance at U.C.I., he has enjoyed the growth of the city, and to be able to contribute to the continued growth of pharmaceutical sciences and industry through the participation on the Dean’s Professional Advisory Group for Chapman University School of Pharmacy.
photo of John Jones, RPh, JD

John Jones, RPh, JD

Senior Vice President of Professional Practice and Pharmacy Policy, OptumRx
Irvine, CA
John Jones is the Senior Vice President of Professional Practice and Pharmacy Policy at OptumRx, a United Health Group Company, in Irvine, California. He is licensed as both a pharmacist and an attorney. He has broad experience with more than 35 years of pharmacy practice ranging from chain and independent community pharmacy to hospital, home infusion and managed care pharmacy. He has applied his legal skills in the fields of managed healthcare legislative policy and regulation, health insurance, healthcare contracting, and interstate regulatory compliance for prescription mail service and pharmacy benefit management companies. John serves as Chairman of the Board of Directors of URAC. URAC accredits more than 600 healthcare companies for quality nationwide via its 24 accreditation programs across the healthcare continuum. John has a long involvement with the Academy of Managed Care Pharmacy where he chaired numerous committees, served on its Board of Directors, as its Treasurer and its President.
John served on the California Board of Pharmacy for eight years, two of those years as its president. He is an active member and leader of the Pharmaceutical Care Management Association (PCMA). He also teaches Law and Ethics at the University of California at San Diego Skaggs School of Pharmacy.
John is a native of Idaho and graduated from Idaho State University with a Bachelor of Science in Pharmacy. He earned his law degree from the University of San Francisco.
photo of Assad J. Kazeminy, PhD

Assad J. Kazeminy, PhD

CEO and Founder of Irvine Pharmaceutical Services, Inc.,
Irvine, CA
Assad J. Kazeminy, Ph.D., is Founder and the former CEO of Irvine Pharmaceutical Services Inc. (CRO ) and Avrio Biopharmaceutical LLC ( CMO ). He has more than 30 years of research experience in Analytical Chemistry and Biochemistry and has been involved in teaching and management aspects for analytical and quality control laboratories for Pharmaceutical, Biopharmaceutical and Nutraceutical companies. He founded those companies in 1988 and 2008. In October 2016 Dr. Kazeminy successfully sold these businesses to one the largest Japanese firm call Nitto Denko Avecia.
Dr. Kazeminy received his Doctorate Degree in Pharmaceutical Sciences from Esfahan University, Esfahan, Iran. He continued his graduate studies in Biochemistry at Colorado State University and completed his post Doctorate at the University of Southern California Medical School, Department of Pharmacology. In addition, Dr. Kazeminy has taught at the USC and has conducted research at the University of California, Irvine.
Dr. Kazeminy served as a Board Member of the Physical Science Dean’s Leadership Council and served as an External Advisor to the Department of Chemistry. Dr. Kazeminy has been executive member of the Association of Analytical Chemists (AOAC) International since 1993 and executive member of the Southern California Discussion Group. In addition, Dr. Kazeminy served as a member of the United States Pharmacopeia (USP) Expert Committee since 2000 where he has also been a member of the USP Convention and the USP advisory panels on Metal Impurity and Residual Solvents. Dr. Kazeminy currently serves on the Board of Directors of TheraVida, Inc a Drug Development company he started in 2005. He is current member of the University of California Irvine, Chief Executive Roundtable since 2005. In addition, Dr. Kazeminy is a member of the Chapman University School of Pharmacy (CUSP) Dean’s Professional Advisory Group since January 2014 and in January 2017, expanded his role to include serving as the Executive Industry Liaison and Adjunct Professor at CUSP.
His leadership in the pharmaceutical industry is extensive with numerous Executive Chair, Chairperson appointments in some other national and international organizations. He is the Board member of the Orange County Pacific Symphony.
Dr. Kazeminy has been awarded by United State Pharmacopeia a Winner for Innovative Responses to a Public Health Challenge related to his outstanding work on a new General Chapter of USP on elemental impurities in parenteral products and the creation of science-based daily exposure risk approach to Patient Safety 2010- 2015.
photo of Chad Kearns, PharmD

Chad Kearns, PharmD

Owner and Director of Pharmacy for CDM Drugs
Corona Del Mar, CA
Dr. Kearns has 25 years of healthcare management experience. He is the co-founder and Vice-President of Creative Outcome Solutions Technology, Inc. dba COSTech® and is co-founder of COSTechtivity®; COSTech's proprietary software package used to collect, compile, report and analyze outcome data. He is also President and CEO of Community Infusion Services, Inc. and KBM Enterprises, Inc. Dr. Kearns has developed Disease Management programs in cooperation with field experts on several disease states and is published in the areas of Continuous Quality Management and Disease State Management.
He received his Doctorate in Pharmacy from the University of Pacific, in Stockton, CA. His clinical training included work at the Tripler Army Medical Center in Honolulu, HI, where he was a team member of a pharmacy management group responsible for the overall medical therapy management of the oncology patients in the outpatient clinic setting. This included the clinical monitoring, management and administration of chemotherapeutic agents and protocols as well as ancillary medications.
Dr. Kearns has held the position of Southern California Infusion Supervisor for Pharmacy Corporation of America (PCA). While at PCA, Dr. Kearns assisted in developing their Home Infusion and Sub-Acute Infusion Programs and Policies and Procedure Manuals for Beverly Enterprises, the parent company of PCA.
Dr. Kearns then went on to hold the position of Director of Pharmacy for Children’s Home Care of Los Angeles (CHLA), the home health program of Children’s Hospital of Los Angeles. In this position, he took the program through JCAHO Accreditation, developed the Patient Care Management Program, oversaw operations and clinical departments managing over 500 pediatric patients and managed the Investigational Protocol Program for the physician’s of CHLA.
Dr. Kearns went on to Modern Healthcare to assist in JCAHO Accreditation and development of their Patient Care Management Program directing the clinical teams assigned to UCLA and Daniel Freeman Medical Center. It is here where his teams monitored and assisted the physician/medical staff in the patient care management of highly complex Bone Marrow Transplant patients (UCLA) and Kidney Transplant patients (Daniel Freeman) in the home setting, giving Dr. Kearns the background and experience which sets him apart today as a well know clinical management expert.
Currently, Dr. Kearns is Owner and Director of Pharmacy for CDM Drugs, a full service pharmacy management program focusing on comprehensive clinical patient management systems that optimize therapeutic outcomes. Dr. Kearns is well known for his clinical management of high acuity, complicated infusion patients with multiple comorbidities and their successful therapy management.
Chad has been very active in his philanthropic organization, the Roosters Foundation, raising money for children’s charities in Orange County. He enjoys spending time with his family, watching his twin boys play football, making wine, cooking and gardening.
photo of Parmis Khatibi, PharmD

Parmis Khatibi, PharmD

Antithrombotic/Anticoagulation Clinical Specialist, University of California Irvine Medical Center
Irvine, CA
Dr. Khatibi manages a whole spectrum of patients in her clinic who require treatment of thromboembolic diseases and associated complications. Her clinical research interests are in venous thromboembolism and the degree of morbidity and mortality associated with this disease. She recently helped implement Medication Safety Clinics at the UCI Medical Center and has served on the Medication Therapy Management task force for CSHP.
Dr. Khatibi received her bachelor’s degree from Texas A&M University and attended The University of the Pacific School of Pharmacy where she earned her doctorate. She completed a post-doctoral/residency training program at Loma Linda University Medical Center. Prior to her matriculation for her doctorate, Parmis was a high school teacher in a poverty-stricken area of south central Los Angeles. She implemented many programs that dealt with gang prevention as well as self-esteem and self-confidence issues for young women.
Parmis is dedicated to learning about and becoming engaged with the most pressing challenges facing future generations and dedicates her time to political and philanthropic causes. She has served in executive board member and committee member capacity for Girls, Inc., Young Executives of America, Blind Children’s Learning Center, California Women’s Leadership Association, World Affairs Council of Orange County, Gen-Next, American Red Cross of Orange County, Zoroastrian Youth of North America, Public Affairs Alliance of Iranian Americans-Next-Gen, and Farhang Foundation.
photo of Dmitri Laptoko, D.Sc., Ph.D.

Dmitri Laptoko, D.Sc., Ph.D.

Director of Laser Sciences, Masimo Corporation
Irvine, CA
Dmitri Lapotko received Ph.D. degree in physics in 1988 in Minsk, Belarus (USSR), for the research in laser weapons, and Doctor of Science degree in thermal physics and bioengineering in 2003 for his research in photothermal cellular effects (Minsk, Belarus). In Belarus, he founded The Laboratory for Laser Cytotechnology (1991-2009). In USA, Lapotko was a faculty at Rice University (Houston, TX, 20010-2015) where he introduced cancer cell theranostics and the concept of non-stationary nano-science. Dr. Lapotko leads the development of new medical nano-technologies at Masimo Corporation (Irvine, CA). He invented the photothermal microscope, plasmonic nanobubbles and cancer- and malaria-aimed nanotechnologies. He authored over 130 research articles, more than 50 conference presentations and 8 patents.
photo of Keith Lewis, RPh, MD

Keith Lewis, RPh, MD

Professor and Chairman Department of Anesthesiology Boston Medical Center Boston University School of Medicine, Vice-President Plexus Management Group, Inc.
Dr. Lewis chairs multiple committees including the Medication Safety and Quality Committee, Surgical Robotics Committee, Simulation Committee, Perioperative Services Guidance Team and is Director of the Operating Room Executive Committee. Dr. Lewis was instrumental in the creation of AAM’s own consultant firm called Plexus Management Group, Inc., serving as Vice-President, providing consultations in perioperative management and leadership around the country.
Dr. Lewis’ areas of expertise include cardiac and vascular anesthesia and motivating change in the health care. Currently, Dr. Lewis is involved in creating OR’s of the Future and developing new health care approaches to streamline patient flow and avoid waits and delays. Dr. Lewis lectures around the country on OR management topics including open vs. block scheduling, managing flow and variability, strategies to minimize risk and positioning your ORs for the future. Dr. Lewis has been involved with the IHI, IHO and the Joint Commission in presentations on managing flow and variability. In addition, Dr. Lewis was instrumental in the design of the Moakley Ambulatory Surgery Center at Boston Medical Center which is a state-of-the-art facility showcasing new and creative innovations.
Dr. Lewis created the Ellison Pierce Symposium hosted annually in Boston entitled, “Positioning Your ORs for the Future” which is in its 8th year and attracts attendees from all over the country and is the first of its kind. Dr. Lewis serves on several Boards including Plexus, the BMC Healthnet and the AAM and BMC malpractice companies (founding member). Bringing organizations to the next level by motivating and maintaining change is one of Dr. Lewis’ main areas of expertise.
photo of Lee Meyer, PharmD, CGP, FASCP

Lee Meyer, PharmD, CGP, FASCP

Long Term Care Facilities and Pharmacies Management Consultant
Irvine, CA
Dr. Meyer focuses on clinical, regulatory, quality assurance and cost containment activities related to medications and drug therapy in advisory capacity to company management. Prior to this role, Dr. Meyer served as the Director of Operations for Pharmacy Advantage, where he developed and ran their pharmacy services. He developed their Medicare Part D program including contract negotiation, facility training and implementation, pharmacy staff education transition policies, prior authorization procedures, and billing and collections procedures.
Dr. Meyer is a Past-President and Chairman of the Board of the American Society of Consultant Pharmacists, and a member of the ASCP Council of Presidents. He currently serves on the Advocacy Council, DEA Task Force and Political Action Committee. He also represents ASCP on the Pharmacy Quality Alliance (PQA) Long Term Care Workgroup. He previously served on the Public Affairs Council and Education Advisory Committee, and has presented at several ASCP meetings.
Dr. Meyer is also active with the California Pharmacists Association serving on the CPhA-CHSP Joint Transitions of Care Task Force, and Chair of the Strategic Planning Committee. He previously served on the CPhA Board of Trustees of the California Pharmacists Association as the representative of the Academy of Long Term Care in 2010-2011, Audit Task Force, Long Term Care Management Council, CEO Search Committee 2010, Best Practices Committee, Emerging Issues Committee. He is also a member of the American Geriatrics Society, serving on the Public Awareness Committee and the Health Systems Innovation – Economics and Technology Committee. Dr. Meyer was guest editor for the California Pharmacist 2011 and has published several articles and presented various long term care pharmacy topics to a variety of audiences in California and nationally.
Dr. Meyer received his BA and PharmD degrees from the University of the Pacific School of Pharmacy in Stockton, California.
photo of Marsha J. Meyer, PharmD, CGP, CGCM

Marsha J. Meyer, PharmD, CGP, CGCM

Clinical Pharmacist, Independence at Home, division of SCAN health plan
Long Beach, CA
Prior to her current roles, Dr. Meyer was extensively involved with long-term care pharmacy in pharmacy operations and as a consultant pharmacist. She has held a senior management position with a large medical education company and has provided consultant services to a national medication inventory and software manufacturer. Dr. Meyer worked for several years in the pharmaceutical industry in the Pharmacy Affairs department. She began her pharmacy career in community pharmacy and also worked as a clinical pharmacist at Duke University Medical Center.
Marsha currently serves on the Board of Directors for the American Society of Consultant Pharmacists (ASCP). She is also the Editor for ASCP’s Geriatric Pharmacy Review, a web-based geriatric pharmacotherapy review and recertification vehicle for the Commission for Certification in Geriatric Pharmacy (CCGP). She was the 2012 recipient of the Armon B. Neel Senior Care Pharmacist Award presented by ASCP. She is a frequent speaker at professional and consumer programs. Dr. Meyer received her BS in Pharmacy from Medical College of Virginia, Virginia Commonwealth University and her PharmD from Rio Grande School of Pharmacy. She is a Certified Geriatric Pharmacist and a Certified Geriatric Care Manager.
photo of Earl Mindell, R.PH., Ph.D.

Earl Mindell, R.PH., Ph.D.

Earl Mindell R.PH., Ph.D., is an internationally recognized expert on Nutrition, Drugs, Vitamins, and Herbal Remedies. Dr. Mindell is often called the Father of the Nutritional Revolution. In 1971, Dr. Mindell co-founded a chain of Vitamin Stores, called Great Earth Vitamins. He is the author of 55 health oriented books that have been translated into 34 languages, including the all time best selling Nutritional book, The New Vitamin Bible, which has sold over 11 million copies, Prescription Alternatives, and The Herb Bible. He is a registered pharmacist, master herbalist and holds a PH.D in nutrition.
Dr Mindell has been awarded the President's Citation for Exemplary Service from Bastyr University for his contributions to the health and well being of humanity. He was inducted into the California Pharmacists Association Hall Of Fame in 2007.He was awarded the President's Award from the National Nutritional Food Association. He is on the Board Of Directors of the California College of Natural Medicine. He served on the International Board of Nutrition for Nestle' International for 6 years. He spoke with Get Motivated from 1999 to 2009 with such luminaries as Colin Powell, Rudy Giuliani, Zig Ziglar, George Bush, Laura Bush, Margaret Thatcher, President Gerald Ford, Elizabeth and Bob Dole, William Shatner, Christopher Reeves.
He has appeared on the Oprah Winfrey Show, Live with Regis and Cathy Lee, Good Morning America, CNN, David Letterman Show and has been on more than 300 radio and TV shows annually.
photo of Mike Pavlovich, PharmD

Mike Pavlovich, PharmD

Co-Owner, Westcliff Compounding
Newport Beach, CA
He is one of two pharmacists ever named to serve as USOC’s Team Pharmacist, and was a member of The USOC Medical Team for the XXIX Olympiad in Beijing. His experience was detailed in a cover story published by Drug Topics in 2008. He has addressed professional healthcare organizations nationwide on a variety of pharmacy-related topics and has advised clients from Major League Baseball, the National Basketball Association, the National Football League, the National Hockey League and the NCAA for over 12 years. He has consulted sports-based clients as far away as Europe and the Middle East. He represented APhA on a joint task force with the National Athletic Trainers’ Association charged with creating guidelines for managing medication use in the athletic training facility and was a contributing author for the “National Athletic Trainers' Association Position Statement: Anabolic-Androgenic Steroids”. He has recently been appointed to the California Department of Justice’s working group charged with reforming the state’s prescription drug monitoring system. He has practiced in long-term care, hospice, mail-service, compounding, and community pharmacy.
Dr. Pavlovich is Past President of the California Pharmacists Association. He has chaired the APhA Policy Committee, and the House of Delegates Nominating Committee; and has served numerous committees of APhA and CPhA. He has been recognized by CPhA as Student of the Year in 1989, and Distinguished Young Pharmacist in1995, and received the American Pharmacists Association Academy of Pharmacy Practice and Management Distinguished Achievement Award in Specialized Pharmacy Practice in 2012. In 1995 he was named to the Honorable Order of Kentucky Colonels.
He is married to Lisa, and is the father of Nicole, Aaron and Ty.
photo of Robert Pollock, BPharm, MS

Robert Pollock, BPharm, MS

Senior Advisor and Outside Director to the Board Lachman Consultant Services, Captain, 0-6 U.S. Public Health Service, Commissioned Corps, Retired
Encinitas, CA
Previous to his time with Lachman, worked in various administrative roles for the United States Public Health Service (USPHS) Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Generic Drugs (OGD) and clinical roles for USPHS. Robert received his Bachelor’s of Science in Pharmacy from the University of Rhode Island and a Masters of Science in Pharmacy Administration from the same institution. He is a Fellow of the American Foundation for Pharmaceutical Education and is credited with many publications and presentations.
Previous to his time with Lachman, worked in various administrative roles for the United States Public Health Service (USPHS) Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Generic Drugs (OGD) and clinical roles for USPHS. Robert received his Bachelor’s of Science in Pharmacy from the University of Rhode Island and a Masters of Science in Pharmacy Administration from the same institution. He is a Fellow of the American Foundation for Pharmaceutical Education and is credited with many publications and presentations.
photo of Michael Rigas, PharmD

Michael Rigas, PharmD

Chief Clinical Officer
KabaFusion, LLC, Cerritos, CA
Before moving to Geisinger, Dr. Rigas served as the Senior Vice President of Clinical Affairs at Crescent HealthCare in Anaheim, California, and VP of Infusion Services at Apria HealthCare, Inc, both large alternate site pharmacy company specializing in infusion and specialty pharmacy therapies.
He graduated from USC School of Pharmacy with his Pharm.D. degree and completed his residency at UC San Francisco Hospitals and Clinics in 1982. He spent the first 10 years of his career in the hospital arena serving as the Chief clinical pharmacist in 3 different 200+ bed community hospitals. From 1998 to 2002 Dr. Rigas managed pharmacies and nursing operations for Apria Healthcare, a nationwide infusion company with 32 pharmacies in 22 states at the Vice President level.
Dr. Rigas’ areas of expertise include Antimicrobial therapy, Immunoglobulin therapies, Nutritional support and Pain control, improving clinical and financial outcomes, and payer and contract relations. He also functions as an expert witness for therapeutic misadventures. Additionally, he works with various private and public groups seeking improved management strategies for High Cost Biologic/Specialty Pharmaceuticals and infusion therapies via standardized coding, billing, and payment levels. He is also deeply involved in improving patient access via Patient Assistance Plans and managing Medicare Part D issues in front of the California board of pharmacy and CMS regional managers.
Dr Rigas holds membership in the American Society of Hospital Pharmacists and the National Home Infusion association.
photo of Ken Tokita, M.D.

Ken Tokita, M.D.

Medical Director
KSK Medical, LLC.
Dr. Tokita is a Radiation Oncologist and Medical Director at KSK Medical, LLC. He received his Bachelors of Science Degree in Chemistry and pursued his medical degree at the University of Washington. He interned at the University of Southern California and underwent residencies for Internal Medicine at the Mayo Clinic and completed his radiation oncology residency at the University of Washington. He proudly served as a U.S. Army physician and was the Founding Director at Torrance Memorial Hospital and St. John’s Health Center. Dr. Tokita eventually settled his practice in Orange County, California. He is the first physician to own and operate a private cancer treatment center with radiation therapy, full diagnostic imaging, and surgical suite. With over 35 years of experience, Dr. Tokita is one of the nation’s foremost experts in radiation therapy. Dr. Tokita has been at the forefront of many cancer treatments. A few of his accomplishments includes the use of ultrasound for prostate cancer, the use of chemotherapy with radiation therapy for breast cancer which improved cure rates, implanting permanent seeds by ultrasound, High Dose Rate Brachytherapy for prostate cancer treatment and the first to research and use spacer material for prostate cancer to protect and minimize rectal injury. Dr. Tokita has developed many other treatment techniques used today and continues to develop advanced techniques that place him on the leading edge in radiation oncology.
photo of Catherine C. Turkel, PharmD, MBA, PhD

Catherine C. Turkel, PharmD, MBA, PhD

Novus Therapeutics, Inc.
Dr. Turkel, President of Novus Therapeutics, is responsible global research and development, as well as commercial strategy and development. She has more than 30 years of combined clinical practice and drug development experience and has successfully led global development project teams resulting in multiple registrations of new drug treatments around the world. Prior to joining Novus Therapeutics in 2015, Dr. Turkel held several R&D leadership positions at Allergan, Inc., including Vice President of Clinical Development for Neurology, Urology, and Pain; Vice president of Global Medical Affairs; and other positions from 1998 to 2015. Prior to Allergan, Dr. Turkel served as Director of Drug Development, Regulatory Affairs, and Data Management at Cypros Pharmaceuticals from 1995 to 1998. Dr. Turkel's industry tenure also includes past positions at IVAC Corporation, California Clinical Trials, and Siemens Infusion Systems, as well as many years as a hospital-based critical care pharmacist. Dr. Turkel has published numerous peer-reviewed journal articles on topics including the use of BOTOX® for the treatment of cerebral palsy spasticity, poststroke spasticity and chronic migraine. In addition, she has numerous publications as a co-author on epidemiology of chronic migraine. Dr Turkel’s work has appeared in such journals as New England Journal of Medicine, Neurology, Headache, Cephalalgia and others. She is lead author or significant co-author on more than 100 abstracts, posters and/or manuscripts. Dr. Turkel holds a Doctor of Pharmacy from the University of the Pacific, an MBA from the University of California, Irvine, and a Doctor of Philosophy in Business from Capella University.